Stevanato Group (NYSE:STVN – Get Free Report) and DIH Holding US (NASDAQ:DHAI – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings and analyst recommendations.
Risk & Volatility
Stevanato Group has a beta of 0.56, indicating that its share price is 44% less volatile than the S&P 500. Comparatively, DIH Holding US has a beta of -0.57, indicating that its share price is 157% less volatile than the S&P 500.
Earnings & Valuation
This table compares Stevanato Group and DIH Holding US”s top-line revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Stevanato Group | $1.17 billion | N/A | $157.62 million | €0.47 ($0.48) | 48.98 |
DIH Holding US | $64.47 million | 0.77 | -$8.44 million | N/A | N/A |
Insider and Institutional Ownership
27.8% of DIH Holding US shares are owned by institutional investors. 49.6% of DIH Holding US shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Profitability
This table compares Stevanato Group and DIH Holding US’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Stevanato Group | 10.47% | 9.86% | 5.79% |
DIH Holding US | N/A | -5.07% | 3.35% |
Analyst Recommendations
This is a breakdown of recent ratings and price targets for Stevanato Group and DIH Holding US, as reported by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Stevanato Group | 0 | 1 | 5 | 0 | 2.83 |
DIH Holding US | 0 | 0 | 0 | 0 | 0.00 |
Summary
Stevanato Group beats DIH Holding US on 8 of the 10 factors compared between the two stocks.
About Stevanato Group
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
About DIH Holding US
DIH Holding US, Inc. operates as a robotics and virtual reality (VR) technology provider for the rehabilitation industry in Europe, the Middle East, Africa, the United States, and the Asia Pacific. It offers ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; ArmeoSpring for less severe patients that provides self-initiated repetitive arm and hand therapy in an extensive workspace; ArmeoSpring Pro; and Armeo Senso, for patients self-initiated and still structurally controlled movement patterns to completely open movement. The company also provides lower extremity products, including Erigo for gradual verticalization, leg mobilization, and intensive sensorimotor stimulation through cyclic leg loading; Lokomat, a robot-assisted therapy that enables training to increase the strength of muscles and a range of motion of joints in order to improve walking; Andago, a robotics smart control system that assists patients in walking naturally; C-Mill, creates a training environment; CAREN, a computer assisted rehabilitation environment; and GRAIL, an gait real-time analysis interactive lab solution for analysis training and research. In addition, it offers SafeGait, RYSEN, and M-Gait for gait and balance; and HocoNet and D-Flow software. DIH Holding US, Inc. was founded in 2021 and is based in Norwell, Massachusetts.
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.